Final Trial Results Confirm Disappointment on CureVac Vaccine - The New York Times

1. Final Trial Results Confirm Disappointment on CureVac Vaccine  The New York Times
2. CureVac, the latest experimental coronavirus vaccine, proves just 48 percent effective overall, a disappointing result  The Washington Post
3. UPDATE 1-CureVac COVID-19 vaccine records only 48% efficacy in final trial readout  Yahoo Finance
4. Coronavirus digest: Curevac jab only 48% effective across age groups  DW (English)
5. German COVID-19 vaccine CureVac has efficacy rate of 48 percent in final trials  Firstpost
6. View Full Coverage on Google News

from Top stories - Google News https://ift.tt/3qDmitm